Skip to main content
Fig. 8 | Retrovirology

Fig. 8

From: HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4+ T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial

Fig. 8

CD4+ T-cell numbers up to week 48 in vaccinees and placebo stratified by quartiles according to baseline values. Baseline values (left panels) and changes from baseline (right panels) of CD4+ T cells in a vaccinees (n = 98), b placebo (n = 100) and c anti-Tat Ab-negative placebo (n = 80). Data are presented as mean values with standard errors. Longitudinal analysis for repeated measures was used. p values assess the changes from baseline within each treatment group

Back to article page

Retrovirology

ISSN: 1742-4690

Contact us